Value of circulating insulin-like growth factor-associated proteins for the detection of stage I non-small cell lung cancer.
暂无分享,去创建一个
Sanjib Basu | Ravi Pithadia | Cristina Fhied | Fabien Maldonado | Shaun Daly | M. Yoder | F. Maldonado | G. Chmielewski | E. Edell | J. Borgia | M. Liptay | C. Seder | S. Basu | Eric S Edell | David D Shersher | Jeffrey A Borgia | Michael J Liptay | Gary Chmielewski | Christopher W Seder | John C Kubasiak | William W Phillips | Mark A Yoder | S. Daly | C. Fhied | J. Kubasiak | Ravi Pithadia | William W. Phillips | D. Shersher
[1] F. Hofmann,et al. The Insulin-Like Growth Factor-I Receptor Kinase Inhibitor, NVP-ADW742, Sensitizes Small Cell Lung Cancer Cell Lines to the Effects of Chemotherapy , 2005, Clinical Cancer Research.
[2] C. Gatsonis,et al. Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening , 2012 .
[3] Pinchas Cohen,et al. Insulin-like growth factor binding protein-3 inhibits the growth of non-small cell lung cancer. , 2002, Cancer research.
[4] J. Beattie,et al. IGFBP-5 enhances epithelial cell adhesion and protects epithelial cells from TGFβ1-induced mesenchymal invasion. , 2013, The international journal of biochemistry & cell biology.
[5] D. Hanahan,et al. Hallmarks of Cancer: The Next Generation , 2011, Cell.
[6] C. Mathers,et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 , 2010, International journal of cancer.
[7] Jinshun Zhao,et al. Expression and clinical significance of IGF-1, IGFBP-3, and IGFBP-7 in serum and lung cancer tissues from patients with non-small cell lung cancer , 2013, OncoTargets and therapy.
[8] P. Cohen,et al. Role of insulin‐like growth factors and their binding proteins in growth control and carcinogenesis , 2000, Journal of cellular physiology.
[9] J. Crowley,et al. The IASLC Lung Cancer Staging Project: Proposals for the Revision of the TNM Stage Groupings in the Forthcoming (Seventh) Edition of the TNM Classification of Malignant Tumours , 2007, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[10] J. Crowley,et al. The IASLC Lung Cancer Staging Project: Validation of the Proposals for Revision of the T, N, and M Descriptors and Consequent Stage Groupings in the Forthcoming (Seventh) Edition of the TNM Classification of Malignant Tumours , 2007, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[11] M. Yoder,et al. Development and Validation of a Plasma Biomarker Panel for Discerning Clinical Significance of Indeterminate Pulmonary Nodules , 2013, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[12] J. Coon,et al. A multi-analyte serum test for the detection of non-small cell lung cancer , 2010, British Journal of Cancer.
[13] B. Mahon,et al. Development of a serum biomarker panel predicting recurrence in stage I non-small cell lung cancer patients. , 2012, The Journal of thoracic and cardiovascular surgery.
[14] David F Yankelevitz,et al. CT screening for lung cancer: update 2007. , 2008, The oncologist.
[15] Ugo Pastorino,et al. Computed tomography screening and lung cancer outcomes. , 2007, JAMA.
[16] J. Klominek,et al. Growth factor-enhanced expression and activity of matrix metalloproteases in human non-small cell lung cancer cell lines. , 2003, Anticancer research.
[17] D. Libby,et al. Tumor size predicts survival within stage IA non-small cell lung cancer. , 2003, Chest.
[18] Sanjib Basu,et al. Establishment of a Multi-Analyte Serum Biomarker Panel to Identify Lymph Node Metastases in Non-small Cell Lung Cancer , 2009, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[19] J. Coon,et al. Enhancement of a multianalyte serum biomarker panel to identify lymph node metastases in non‐small cell lung cancer with circulating autoantibody biomarkers , 2011, International journal of cancer.
[20] Sanjib Basu,et al. Development of a Multiplexed Tumor-Associated Autoantibody-Based Blood Test for the Detection of Non–Small Cell Lung Cancer , 2010, Clinical Cancer Research.
[21] O. Miettinen,et al. Survival of Patients with Stage I Lung Cancer Detected on CT Screening , 2008 .
[22] A. Kornblihtt,et al. Varying patterns of expression of insulin‐like growth factors I and II and their receptors in murine mammary adenocarcinomas of different metastasizing ability , 1996, International journal of cancer.
[23] B. Mahon,et al. Biomarkers of the insulin-like growth factor pathway predict progression and outcome in lung cancer. , 2011, The Annals of thoracic surgery.
[24] Debra T Silverman,et al. Serum IGF-I, IGF-II, IGFBP-3, and IGF-I/IGFBP-3 Molar Ratio and Risk of Pancreatic Cancer in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial , 2010, Cancer Epidemiology, Biomarkers & Prevention.
[25] Guanghui Wang,et al. Association between Circulating Levels of IGF-1 and IGFBP-3 and Lung Cancer Risk: A Meta-Analysis , 2012, PloS one.
[26] Matthijs Oudkerk,et al. International Association for the Study of Lung Cancer Computed Tomography Screening Workshop 2011 report. , 2012, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.